<DOC>
	<DOCNO>NCT00624312</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness two-dose regimen Procrit prior major surgical oncology operation .</brief_summary>
	<brief_title>Procrit Versus Placebo Determine Efficacy Pre-Operative Major Surgical Oncology Operations</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Undergoing major surgical oncology procedure define : Pancreatectomy Hepatectomy Esophagectomy Gastrectomy Retroperitoneal Sarcoma Resection 18 year age old Hemoglobin level ≥ 10g/dL &lt; 13g/dL , within 10 day enrollment If female childbearing potential , negative pregnancy test within 14 day prior surgery If subject sexually active male sexually active female child bear potential , subject agrees use medically accept form contraception time enrollment completion followup study visit IRBapproved inform consent , sign subject subject 's legally authorize representative ≥ 18 year age Preoperative hemoglobin level ≥ 13g/dL &lt; 10g/dL Uncontrolled hypertension ( define systolic pressure ≥ 160 and/or diastolic pressure ≥ 110 ) History allergy Procrit® Known hypersensitivity mammalian cellderived product human albumin History spontaneous venous thrombotic vascular event Anemia due factor cancer , ( e.g . iron deficiency , B12 deficiency ) History ( within 12 month ) deep venous thrombosis ( DVT ) , pulmonary embolus ( PE ) , venous thrombotic event . Prior superficial thrombophlebitis exclusion criterion History ( within 6 month ) uncontrolled cardiac arrhythmia , cerebrovascular accident ( CVA ) , transient ischemic attack ( TIA ) , acute coronary syndrome ( ACS ) , arterial thrombosis . ACS include Unstable Angina , Q wave Myocardial Infarction ( QwMI ) , nonQ wave myocardial infarction ( NQMI ) Currently receive therapeutic prophylactic anticoagulant condition plan surgery . The exception low dose aspirin ( ≤ 325 mg/day ) low dose anticoagulant maintain patency intravenous ( IV ) line Patient candidate autologous blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Procrit</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Patients undergo major surgical oncology operation</keyword>
</DOC>